{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:06:27Z","timestamp":1780967187827,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA033182"],"award-info":[{"award-number":["R21DA033182"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50DA018165 07"],"award-info":[{"award-number":["P50DA018165 07"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA015815"],"award-info":[{"award-number":["UG1DA015815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA007262"],"award-info":[{"award-number":["T32DA007262"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32AA007468"],"award-info":[{"award-number":["T32AA007468"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Veterans Affairs Clinical Sciences Research and Development (Merit Review Program (WFH)"},{"name":"Medical Research Foundation (MK)"},{"name":"Collins Medical Trust (MK)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.drugalcdep.2018.07.045","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T20:07:31Z","timestamp":1537560451000},"page":"186-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder"],"prefix":"10.1016","volume":"192","author":[{"given":"Milky","family":"Kohno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"McCready","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5556-3597","authenticated-orcid":false,"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0005","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/BF02532382","article-title":"Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation","volume":"21","author":"Azaryan","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1996.66020443.x","article-title":"Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions","volume":"66","author":"Azaryan","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s007020170038","article-title":"Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics","volume":"108","author":"Braus","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2006.09.002","article-title":"Initial evidence for the reliability and validity of a \"Lite\" version of the Addiction Severity Index","volume":"87","author":"Cacciola","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainresbull.2005.05.028","article-title":"Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone","volume":"67","author":"Chiu","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/add.13950","article-title":"Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial","volume":"113","author":"Coffin","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.biopsych.2012.01.027","article-title":"Endogenous opioid release in the human brain reward system induced by acute amphetamine administration","volume":"72","author":"Colasanti","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0040","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1038\/npp.2016.99","article-title":"The effects of pharmacological opioid blockade on neural measures of drug cue-reactivity in humans","volume":"41","author":"Courtney","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0045","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/brb3.289","article-title":"Childhood maltreatment and amygdala connectivity in methamphetamine dependence: a pilot study","volume":"4","author":"Dean","year":"2014","journal-title":"Brain Behav."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1360-0443.2001.961333.x","article-title":"Theories of drug craving, ancient and modern","volume":"96","author":"Drummond","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0055","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1073\/pnas.1602413113","article-title":"Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates","volume":"113","author":"Eklund","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08897070802218554","article-title":"Pharmacotherapy of methamphetamine addiction: an update","volume":"29","author":"Elkashef","year":"2008","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/bjp.2008.51","article-title":"The neurocircuitry of addiction: an overview","volume":"154","author":"Feltenstein","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0070","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1176\/appi.ajp.157.11.1789","article-title":"Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli","volume":"157","author":"Garavan","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0075","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0080","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biopsych.2005.02.026","article-title":"Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving","volume":"57","author":"Gorelick","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.biopsych.2008.11.022","article-title":"A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania","volume":"65","author":"Grant","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.euroneuro.2010.06.018","article-title":"A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence","volume":"20","author":"Grant","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00213-004-1828-4","article-title":"Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics","volume":"175","author":"Grusser","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/aje\/kwr193","article-title":"The PhenX toolkit: get the most from your measures","volume":"174","author":"Hamilton","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1207\/S15374424JCCP3104_5","article-title":"Sex differences in young children who meet criteria for attention deficit hyperactivity disorder","volume":"31","author":"Hartung","year":"2002","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0110","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","article-title":"Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","volume":"165","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0115","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","article-title":"Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence","volume":"33","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","article-title":"Improved optimization for the robust and accurate linear registration and motion correction of brain images","volume":"17","author":"Jenkinson","year":"2002","journal-title":"NeuroImage"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00213-003-1393-2","article-title":"Brain circuitry and the reinstatement of cocaine-seeking behavior","volume":"168","author":"Kalivas","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","article-title":"Pharmacological approaches to methamphetamine dependence: a focused review","volume":"69","author":"Karila","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004850-200109000-00006","article-title":"An open naltrexone treatment study in pathological gambling disorder","volume":"16","author":"Kim","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamapsychiatry.2014.399","article-title":"Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence","volume":"71","author":"Kohno","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0145","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/mp.2015.223","article-title":"Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users","volume":"21","author":"Kohno","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fpsyt.2017.00182","article-title":"Executive control and striatal resting-state network interact with risk factors to influence treatment outcomes in alcohol-use disorder","volume":"8","author":"Kohno","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2018.04.037","article-title":"The relationship between interleukin-6 and functional connectivity in methamphetamine users","volume":"677","author":"Kohno","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(11)61331-7","article-title":"Injectable extended-release naltrexone for opioid dependence","volume":"378","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2014.10.044","article-title":"Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging","volume":"1628","author":"London","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuroimage.2013.03.055","article-title":"Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study","volume":"78","author":"Lukas","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0180","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1111\/acer.12546","article-title":"Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging","volume":"38","author":"Mann","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0185","first-page":"143","article-title":"Binge eating disorder: response to naltrexone","volume":"19","author":"Marrazzi","year":"1995","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0190","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1523\/JNEUROSCI.4177-03.2004","article-title":"Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior","volume":"2","author":"McFarland","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0200","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1017\/S1461145714000704","article-title":"Amphetamine induced endogenous opioid release in the human brain detected with [(1)(1)C]carfentanil PET: replication in an independent cohort","volume":"17","author":"Mick","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0205","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/adb.12503","article-title":"Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals","volume":"23","author":"Morris","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archpsyc.65.4.466","article-title":"Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people","volume":"65","author":"Myrick","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0215","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1530-0277.2007.00347.x","article-title":"Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial","volume":"31","author":"O\u2019Malley","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0220","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(91)91452-7","article-title":"Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration","volume":"567","author":"Piazza","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.addbeh.2018.01.021","article-title":"Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis","volume":"80","author":"Potvin","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0230","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.neuroimage.2011.10.018","article-title":"Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion","volume":"59","author":"Power","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0235","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/npp.2015.83","article-title":"The effects of naltrexone on subjective response to methamphetamine in a clinical sample: a double-blind, placebo-controlled laboratory study","volume":"40","author":"Ray","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/104012371002200108","article-title":"Augmentation with naltrexone to treat compulsive sexual behavior: a case series","volume":"22","author":"Raymond","year":"2010","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0245","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00213-017-4607-8","article-title":"Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder","volume":"234","author":"Roche","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"issue":"Suppl. 20","key":"10.1016\/j.drugalcdep.2018.07.045_bib0250","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0255","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1111\/acer.12581","article-title":"Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients","volume":"38","author":"Spagnolo","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1472-8206.2006.00459.x","article-title":"Preclinical and clinical pharmacology of alcohol dependence","volume":"21","author":"Tambour","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2018.07.045_bib0265","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1360-0443.2007.01772.x","article-title":"Approaches to the development of medications for the treatment of methamphetamine dependence","volume":"102","author":"Vocci","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0270","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","article-title":"Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction","volume":"26","author":"Volkow","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0275","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.neuroimage.2007.09.059","article-title":"Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues","volume":"39","author":"Volkow","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0280","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/sj.npp.1301194","article-title":"Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving","volume":"31","author":"Wong","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0285","series-title":"Functional MRI: An Introduction to Methods: Statistical Analysis of Activation Images. Oxford Scholarship Online","author":"Worsley","year":"2011"},{"key":"10.1016\/j.drugalcdep.2018.07.045_bib0290","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1360-0443.2010.03066.x","article-title":"Withdrawal symptoms in abstinent methamphetamine-dependent subjects","volume":"105","author":"Zorick","year":"2010","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618305957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618305957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:59:06Z","timestamp":1759827546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618305957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":58,"alternative-id":["S0376871618305957"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.07.045","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}